These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 29407946)

  • 1. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
    Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
    Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
    Li ZH; Yang DX; Geng PF; Zhang J; Wei HM; Hu B; Guo Q; Zhang XH; Guo WG; Zhao B; Yu B; Ma LY; Liu HM
    Eur J Med Chem; 2016 Nov; 124():967-980. PubMed ID: 27771599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
    Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents.
    Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y
    Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents.
    Liu Z; Wang Y; Lin H; Zuo D; Wang L; Zhao Y; Gong P
    Eur J Med Chem; 2014 Oct; 85():215-27. PubMed ID: 25086238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents.
    Xu C; Zhou W; Dong G; Qiao H; Peng J; Jia P; Li Y; Liu H; Sun K; Zhao W
    Bioorg Chem; 2020 Dec; 105():104424. PubMed ID: 33161253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo.
    Zhao M; Ren H; Chang J; Zhang D; Yang Y; He Y; Qi C; Zhang H
    Eur J Med Chem; 2016 Aug; 119():183-96. PubMed ID: 27162123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antiproliferative activity of novel 5-nitropyrimidine-2,4-diamine derivatives bearing alkyl acetate moiety.
    Zhao PL; Li YH; Yang HK; Chen P; Zhang B; Sun Q; Li Q; You WW
    Eur J Med Chem; 2016 Aug; 118():161-9. PubMed ID: 27128180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unexpected Dimroth rearrangement leading to annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity.
    Lauria A; Patella C; Abbate I; Martorana A; Almerico AM
    Eur J Med Chem; 2013 Jul; 65():381-8. PubMed ID: 23747807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents.
    Ma LY; Wang B; Pang LP; Zhang M; Wang SQ; Zheng YC; Shao KP; Xue DQ; Liu HM
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1124-8. PubMed ID: 25655718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol.
    Lauria A; Abbate I; Patella C; Martorana A; Dattolo G; Almerico AM
    Eur J Med Chem; 2013 Apr; 62():416-24. PubMed ID: 23395722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities.
    Yang F; Yu LZ; Diao PC; Jian XE; Zhou MF; Jiang CS; You WW; Ma WF; Zhao PL
    Bioorg Chem; 2019 Nov; 92():103260. PubMed ID: 31525523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
    Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
    Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
    J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives.
    Cai J; Zhang S; Zheng M; Wu X; Chen J; Ji M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):806-10. PubMed ID: 22217877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
    Shi JB; Tang WJ; Qi XB; Li R; Liu XH
    Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Green Synthesis of Thieno[2,3-d]pyrimidine Analogues as Potential Antiproliferative Agents.
    Gill RK; Kumar V; Bishnoi M; Yadav K; Kondepudi KK; Bariwal J
    Anticancer Agents Med Chem; 2017; 17(5):701-711. PubMed ID: 27539315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [1,2,3]Triazolo[4,5-d]pyrimidine derivatives incorporating (thio)urea moiety as a novel scaffold for LSD1 inhibitors.
    Li ZH; Ma JL; Liu GZ; Zhang XH; Qin TT; Ren WH; Zhao TQ; Chen XH; Zhang ZQ
    Eur J Med Chem; 2020 Feb; 187():111989. PubMed ID: 31881456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.